• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Neptune Medical Appoints Dr. Fred Moll as Chairman of the Board

    11/20/23 8:00:00 AM ET
    $PRCT
    $SWAV
    Medical/Dental Instruments
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $PRCT alert in real time by email

    Neptune Medical, a leading innovator in medical technology, is pleased to announce the appointment of Dr. Fred Moll as Chairman of the Board. Dr. Moll, a seasoned entrepreneur and influential figure in the medical technology industry considered to be the father of medical robotics, brings a wealth of experience and expertise to Neptune Medical.

    Dr. Fred Moll is currently a Managing Partner at Sonder Capital, a venture capital firm focused on investing in breakthrough healthcare technologies. His illustrious career includes founding Intuitive Surgical, a pioneer in robotic-assisted minimally invasive surgery, and Auris Health, which was acquired by Johnson & Johnson.

    In addition to his role at Sonder Capital, Dr. Moll currently serves on the boards of several healthcare companies, including Procept BioRobotics, Inc. (NASDAQ:PRCT) as Chairman, and ShockWave Medical (NASDAQ:SWAV), contributing his strategic vision and leadership to guide these companies in their respective fields.

    "We are thrilled to welcome Dr. Fred Moll as the Chairman of the Board at Neptune Medical," said Alex Tilson, Founder and CEO of Neptune Medical. "His unparalleled experience in the medical technology sector will be invaluable as we continue to grow and advance our mission of transforming healthcare with innovative products."

    As Chairman of the Board, Dr. Moll will provide strategic guidance and leadership to Neptune Medical, supporting the company in its mission to develop cutting-edge medical technologies that improve patient outcomes and enhance the efficiency of healthcare delivery across multiple clinical areas.

    "I am honored to join Neptune Medical as Chairman of the Board," said Dr. Fred Moll. "I am excited about the opportunity to work with the talented team at Neptune Medical and contribute to the development of groundbreaking medical technologies that have the potential to make a significant impact on patient care."

    About Neptune Medical

    Neptune Medical is a Burlingame, Calif.-based medical technology company dedicated to developing innovative solutions that address the challenges faced by healthcare professionals and improve patient outcomes.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231120048805/en/

    Get the next $PRCT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PRCT
    $SWAV

    CompanyDatePrice TargetRatingAnalyst
    PROCEPT BioRobotics Corporation
    $PRCT
    12/2/2024$105.00Overweight
    Morgan Stanley
    PROCEPT BioRobotics Corporation
    $PRCT
    11/14/2024$95.00Hold
    Jefferies
    Shockwave Medical Inc.
    $SWAV
    4/5/2024Outperform → Peer Perform
    Wolfe Research
    Shockwave Medical Inc.
    $SWAV
    3/27/2024$368.00Buy
    CL King
    Shockwave Medical Inc.
    $SWAV
    9/29/2023$218.00Neutral
    UBS
    PROCEPT BioRobotics Corporation
    $PRCT
    8/11/2023$42.00Overweight
    Piper Sandler
    Shockwave Medical Inc.
    $SWAV
    7/10/2023$291.00 → $335.00Equal-Weight → Overweight
    Morgan Stanley
    PROCEPT BioRobotics Corporation
    $PRCT
    5/31/2023Outperform
    William Blair
    More analyst ratings